Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05501548
Title Phase II Study of PARP Inhibitor Olaparib and IV Ascorbate in Castration Resistant Prostate Cancer
Recruitment Not yet recruiting
Gender male
Phase Phase II
Variant Requirements Yes
Sponsors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Indications

castration-resistant prostate carcinoma

Therapies

Olaparib

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST